South Korea
A snapshot of PrEP scale-up, registration and resources for South Korea.

-
NoneEstimated Cumulative Number of People Initiating PrEP
Aggregates numbers reported from demonstration projects, PEPFAR dashboard and program/country reports where available. This is presented as a range due to difficulty in tracking precise numbers and possible double reporting.
Data Updated: April 11, 2022
Drug Registration Status
-
Gilead's Truvada (TDF/FTC) registrationApproved
-
Generic versions of TDF/FTC for preventionNot submitted
-
Viiv’s Apretude (CAB for PrEP) RegistrationNot approved
-
IPM’s Dapivirine Ring RegistrationNot approved
Resources for South Korea
- A Framework for Scaling Up PrEP can help implementers, government and advocates begin planning for and implementing PrEP programs.
- Click here for the latest information from the South Korea Ministry of Health & Welfare.
- APCOM is a coalition governments, United Nations agencies, non-profit organisations and community based organisations from Asia and the Pacific, working together to address HIV issues that affect the lives of men who have sex with men and transgender people. Click here to access PrEPMAP, their new guide to accessing PrEP in the region.
Policy Framework
- Summary of Guidelines for the Use of Pre-Exposure Prophylaxis for HIV in Korea
- Strategy for Implementing HIV PrEP in Korea, 2017
Resources for South Korea
- A Framework for Scaling Up PrEP can help implementers, government and advocates begin planning for and implementing PrEP programs.
- Click here for the latest information from the South Korea Ministry of Health & Welfare.
- South Korea CDC HIV Prevention